Akari Therapeutics PLC(AKTX),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

AKTX Akari Therapeutics PLC

Closed 10-21 16:00:00 EDT

8.76

-0.53

-5.71%

盘后8.76

+0.000.00%

17:13 EDT

High9.94	Low8.70	Vol30.60K
Open9.29	D1 Closing9.29	Amplitude13.33%
Mkt Cap20.02M	Tradable Cap6.08M	Total Shares2.29M
T/O284.28K	T/O Rate4.41%	Tradable Shares694.50K
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"AKTX","market":"US","secType":"STK","nameCN":"Akari Therapeutics PLC","latestPrice":8.76,"timestamp":1792612800000,"preClose":9.29,"halted":0,"volume":30596,"hourTrading":{"tag":"盘后","latestPrice":8.76,"preClose":8.76,"latestTime":"17:13 EDT","volume":1,"amount":8.45,"timestamp":1792617203413,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":-0.057050592034445576,"floatShares":694500,"shares":2285200,"eps":-23.938816,"marketStatus":"Closed","change":-0.53,"latestTime":"10-21 16:00:00 EDT","open":9.29,"high":9.9387,"low":8.7,"amount":284283,"amplitude":0.133337,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-23.938816,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1792656000000},"marketStatusCode":5,"adr":1,"adrRate":80000,"exchange":"NASDAQ","adjPreClose":9.29,"preHourTrading":{"tag":"盘前","latestPrice":9.02,"preClose":9.29,"latestTime":"07:21 EDT","volume":26,"amount":234.51999999999998,"timestamp":1792581662992,"change":-0.27,"changeRate":-0.029064,"amplitude":0},"postHourTrading":{"tag":"盘后","latestPrice":8.76,"preClose":8.76,"latestTime":"17:13 EDT","volume":1,"amount":8.45,"timestamp":1792617203413,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.67531,"impliedVol":1.7186,"impliedVolPercentile":0.7582},"requestUrl":"/m/hq/s/AKTX/tweets","defaultTab":"tweets","newsList":[{"id":"2676682969","title":"European Equities Traded in the US as American Depositary Receipts Decline in Monday Trading","url":"https://stock-news.laohu8.com/highlight/detail?id=2676682969","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2676682969?lang=en_us&edition=fundamental","pubTime":"2026-10-19 23:13","pubTimestamp":1792422833,"startTime":"0","endTime":"0","summary":"European equities traded in the US as American depositary receipts opened the week lower late Monday morning, declining 0.65% to 1,891.99 on the S&P Europe Select ADR Index.From continental Europe, the gainers were led by biotech firm Evaxion  and medical device maker EDAP TMS , which advanced 13% and 2.2% respectively. They were followed by internet browser company Opera  and telecommunications company Nokia , which increased 1.1% and 0.9% respectively.The decliners from continental Europe were led by biopharmaceutical company Cellectis  and pharmaceutical company Sanofi , which dropped 4.8% and 2.1% respectively. They were followed by petroleum refiner Equinor  and telecommunications company Ericsson , which lost 1.9% and 1.7% respectively.The gainers from the UK were led by pharmaceutical company Silence Therapeutics  and biopharmaceutical company Akari Therapeutics , which surged 125% and 14% respectively. They were followed by biopharmaceutical companies Amarin  and Mereo BioPharm","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["IE00BMPRXR70.SGD","BK4134","BK4207","LU0084288595.USD","BCS","BK4532","DAVA.AU","SLN","BK4547","BK4505","LNOK","BK4007","BK4107","BK4554","SNY","BK4117","IE00BFXG1179.USD","BK4521","ERIC","BDRX","BK4585","BK4208","BK4591","BK4515","BK4139","LFGY","ALTX","AKTX","AFG","BK4213","AMRN","BK4588","BK4082","EQNR","NGG","CLLS","BK4201","OPRA","BK4023","DAVA","IE00BMPRXN33.USD","FOCL","NOK","EPV","IEUR","EVAX","LU0006061336.USD","LU0648005311.SGD","MREO","BK4020"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2676512308","title":"Akari Therapeutics Grants Director Bazemore Restricted Stock Units in Lieu of Unpaid Cash Retainers","url":"https://stock-news.laohu8.com/highlight/detail?id=2676512308","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2676512308?lang=en_us&edition=fundamental","pubTime":"2026-10-17 05:21","pubTimestamp":1792185666,"startTime":"0","endTime":"0","summary":"Akari Therapeutics grants director Bazemore restricted stock units in lieu of unpaid cash retainersAkari Therapeutics granted director Robert B. Bazemore stock options covering 60,000 American Deposit","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261016:nNDL2kv24g:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4007","AKTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2675803935","title":"Akari Therapeutics Targets Mid-2027 Start for AKTX-101 Phase 1 Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2675803935","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2675803935?lang=en_us&edition=fundamental","pubTime":"2026-10-15 21:21","pubTimestamp":1792070463,"startTime":"0","endTime":"0","summary":"Akari Therapeutics Targets Mid-2027 Start for AKTX-101 Phase 1 TrialAkari Therapeutics is advancing AKTX-101 through preclinical safety studies and manufacturing, targeting Phase 1 clinical developmen","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261015:nNDL2ZQCPY:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","IE00BQXX3D17.EUR","LU0314104364.USD","SG9999014021.USD","IE00BN0W2V16.EUR","BCDF","IE00B3QW5Z07.USD","BK4585","BK4139","IE00BKPKM429.USD","AKTX","LU2210150020.SGD","IE00BQXX3F31.USD","SG9999014013.SGD","NDAQ","SG9999014005.SGD","BK4112","IE00BN0W2W23.USD","IE00BQXX3C00.GBP","IE00BN0W2T93.GBP","SG9999014039.USD","LU2095319765.USD","IE00B64PRP62.GBP","BK4007","LU2210149790.SGD","IE00BGHQF748.EUR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2675320826","title":"Akari Therapeutics Files Initial Beneficial Ownership Statement for Chief Business Officer Vatnak Vat-Ho","url":"https://stock-news.laohu8.com/highlight/detail?id=2675320826","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2675320826?lang=en_us&edition=fundamental","pubTime":"2026-10-15 05:21","pubTimestamp":1792012861,"startTime":"0","endTime":"0","summary":"Akari Therapeutics Files Initial Beneficial Ownership Statement for Chief Business Officer Vatnak Vat-HoAkari Therapeutics filed an initial statement of beneficial ownership for Chief Business Officer Vatnak Vat-Ho.Disclaimer:This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Akari Therapeutics plc published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on October 14, 2026, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261014:nNDLxgTNd:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","AKTX","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2675432341","title":"European Equities Traded in the US as American Depositary Receipts Edge Lower in Wednesday Trading","url":"https://stock-news.laohu8.com/highlight/detail?id=2675432341","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2675432341?lang=en_us&edition=fundamental","pubTime":"2026-10-14 23:10","pubTimestamp":1791990604,"startTime":"0","endTime":"0","summary":"European equities traded in the US as American depositary receipts were marginally lower late Wednesday morning, declining 0.04% to 1,880.82 on the S&P Europe Select ADR Index.From continental Europe, the gainers were led by biopharmaceutical companies argenx  and Grifols , which advanced 3.4% and 1.8% respectively. They were followed by biopharmaceutical company Cellectis  and medical device maker EDAP TMS , which increased 1.4% and 1.2% respectively.The decliners from continental Europe were led by accommodations booking site trivago  and internet browser company Opera , which fell 2.4% and 1.8% respectively. They were followed by lenders Banco Bilbao Vizcaya Argentaria  and Banco Santander , which were down 1.6% and 1.5% respectively.The gainers from the UK were led by biopharmaceutical company Biodexa Pharmaceuticals  and pharmaceutical company AstraZeneca , which climbed 26% and 3.6% respectively. They were followed by biotech firm Autolus Therapeutics  and pharmaceutical company ","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU0432979614.USD","BK4588","IBB","IE0009355771.USD","LU2237443549.SGD","ARGX","COAL","LU0708994859.HKD","EPV","BK4117","LU2236285917.USD","AFG","LU0310800965.SGD","LU0289739699.SGD","GSK.UK","BK4107","FOCL","SAN.AU","BHP.AU","LU2456880835.USD","AKTX","OPRA","FMED","GSIB","HSBH","AUTL","AZNH","MREO","GSK","IEUR","SLX","TRVG","LU2237443622.USD","GSKH","LFGY","LU0496365809.HKD","LU2237443465.HKD","TBXU","LU0211326755.USD","LU0300736062.USD","SAN","BHP","AZN","LU0889565916.HKD","CLLS","BDRX","LU2237443978.SGD","BBVA","GRFS","HSBC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2675357547","title":"Akari Therapeutics appoints Vatnak Vat-Ho as chief business officer","url":"https://stock-news.laohu8.com/highlight/detail?id=2675357547","media":"TIPRANKS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2675357547?lang=en_us&edition=fundamental","pubTime":"2026-10-13 21:15","pubTimestamp":1791897348,"startTime":"0","endTime":"0","summary":"Akari Therapeutics (AKTX) announced the appointment of Vatnak Vat-Ho as chief business officer. Most recently, Vat-Ho was chief business officer of...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/akari-therapeutics-appoints-vatnak-vat-ho-as-chief-business-officer-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/akari-therapeutics-appoints-vatnak-vat-ho-as-chief-business-officer-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","BK4139","LENZ","AKTX","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2675035215","title":"Press Release: Akari Therapeutics Appoints Accomplished Oncology and ADC Deal Executive Vatnak Vat-Ho as Chief Business Officer to Drive Strategic Growth and Partnering","url":"https://stock-news.laohu8.com/highlight/detail?id=2675035215","media":"Dow Jones","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2675035215?lang=en_us&edition=fundamental","pubTime":"2026-10-13 21:01","pubTimestamp":1791896460,"startTime":"0","endTime":"0","summary":"Mr. Vat-Ho's appointment adds more than 20 years of oncology, biopharma and capital markets experience, including senior roles in transactions totaling more than $25 billion in aggregate valueMr. Vat-","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4539","BK4007","BK4139","AKTX","LENZ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2674806452","title":"European Equities Traded in the US as American Depositary Receipts Open Higher in Monday Trading","url":"https://stock-news.laohu8.com/highlight/detail?id=2674806452","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2674806452?lang=en_us&edition=fundamental","pubTime":"2026-10-12 23:14","pubTimestamp":1791818092,"startTime":"0","endTime":"0","summary":"European equities traded in the US as American depositary receipts started the week modestly higher late Monday morning, rising 0.19% to 1,884.14 on the S&P Europe Select ADR Index.From continental Europe, the gainers were led by petroleum refiner Equinor  and oil and gas company Eni , which increased 2% and 1.5% respectively. They were followed by medical device maker EDAP TMS  and healthcare tech company Royal Philips , which were up 1.9% and 1.3% respectively.The decliners from continental Europe were led telecommunications company Nokia  and biopharmaceutical company DBV Technologies , which dropped 3% and 2.8% respectively. They were followed by biopharmaceutical company Cellectis  and telecommunications company Ericsson , which lost 4% and 1.7% respectively.The gainers from the UK were led by alcoholic beverage company Diageo  and lender HSBC , which advanced 1.3% and 1.4% respectively. They were followed by oil and gas companies Shell  and BP , which rose 1.4% and 1.2% respectiv","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4554","LU1829250122.USD","HSBC","LNOK","IEO","EQNR","USE","LU0211326839.USD","DGE.UK","BPH","AFG","HSBH","SHEL","DRIP","IE00BMPRXN33.USD","LU0052756011.USD","XES","DIG","DBC","DBVT","WTIU","LU0098860793.USD","FTXN","EPV","ERX","LU1267930227.SGD","PXJ","AMRN","CLLS","AKTX","IEUR","ERIC","PXE","E","FOCL","DEO","DBE","IXC","BDRX","GUSH","BK4588","MREO","PHG","DRLL","VDE","NOK","BP","SHEH","LU0320765646.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2674868777","title":"European Equities Traded in the US as American Depositary Receipts Rise in Friday Trading; Flat for Week","url":"https://stock-news.laohu8.com/highlight/detail?id=2674868777","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2674868777?lang=en_us&edition=fundamental","pubTime":"2026-10-09 23:14","pubTimestamp":1791558899,"startTime":"0","endTime":"0","summary":"European equities traded in the US as American depositary receipts were tracking higher late Friday morning, rising 0.42% to 1,881.24 on the S&P Europe Select ADR Index, which is little changed for th","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4559","VOD","TRIB","LU0084288595.USD","AFG","DEO","DGE.UK","IEUR","EPV","OPRA","BK7119","LNOK","BK4134","IE0009355771.USD","SLN","PRNT","ARGX","LU0648005311.SGD","AKTX","ING","BK4568","IE0034235188.USD","DAVA","NOK","IE0002141913.USD","MTLS","FOCL","IBB","LU0109394709.USD","BK4132","BK4532","LFGY","BK4139","IE00BMPRXR70.SGD","DAVA.AU","BDRX","BK4107","IE00B2B36J28.USD","NGG","BUD","LU2324357040.USD","ING.AU","BK4505","BK4007","BK4546","TBXU","BUD.AU","BNTX","FMED","BK4548"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672762176","title":"Akari Therapeutics Raises CEO Abizer Gaslightwala Base Salary to $625,000","url":"https://stock-news.laohu8.com/highlight/detail?id=2672762176","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672762176?lang=en_us&edition=fundamental","pubTime":"2026-10-02 04:46","pubTimestamp":1790887574,"startTime":"0","endTime":"0","summary":"Akari Therapeutics raises CEO Abizer Gaslightwala base salary to $625,000Akari Therapeutics amended CEO Abizer Gaslightwala’s employment agreement on Sept. 29, 2026.Annual base salary raised to $625,0","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261001:nNDL8cwJ4x:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AKTX","BK4139","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672752032","title":"Akari Therapeutics expands IP portfolio with PCT filing for ADC payload","url":"https://stock-news.laohu8.com/highlight/detail?id=2672752032","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672752032?lang=en_us&edition=fundamental","pubTime":"2026-10-01 20:36","pubTimestamp":1790858214,"startTime":"0","endTime":"0","summary":"Akari Therapeutics (AKTX) announced the filing of PCT/US2026/45955, expanding the Company’s intellectual property portfolio around its novel splici...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/akari-therapeutics-expands-ip-portfolio-with-pct-filing-for-adc-payload-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/akari-therapeutics-expands-ip-portfolio-with-pct-filing-for-adc-payload-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["AKTX","NXTI","BK4007","BK4139","LENZ","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672521837","title":"Akari Therapeutics Files PCT Patent Application for PH1 RNA-Splicing ADC Payload in Cancer","url":"https://stock-news.laohu8.com/highlight/detail?id=2672521837","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672521837?lang=en_us&edition=fundamental","pubTime":"2026-10-01 20:25","pubTimestamp":1790857539,"startTime":"0","endTime":"0","summary":"Akari Therapeutics files PCT patent application for PH1 RNA-splicing ADC payload in cancerAkari Therapeutics filed a PCT patent application covering its PH1 ADC payload designed to disrupt RNA splicin","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261001:nNDLc4wWzk:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","IE00B64PRP62.GBP","IE00BN0W2T93.GBP","LU2210150020.SGD","AKTX","BCDF","SG9999014039.USD","IE00BQXX3C00.GBP","BK4585","IE00BQXX3D17.EUR","BK4139","IE00BN0W2V16.EUR","LU0314104364.USD","SG9999014013.SGD","BK4007","IE00BGHQF748.EUR","LU2210149790.SGD","LU2095319765.USD","IE00BN0W2W23.USD","IE00B3QW5Z07.USD","BK4112","IE00BKPKM429.USD","SG9999014005.SGD","IE00BQXX3F31.USD","NDAQ","SG9999014021.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672752924","title":"Akari Therapeutics Expands Intellectual Property Portfolio with Pct Filing for ADC Payload Related to Rna Splicing in Cancers","url":"https://stock-news.laohu8.com/highlight/detail?id=2672752924","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672752924?lang=en_us&edition=fundamental","pubTime":"2026-10-01 20:25","pubTimestamp":1790857503,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261001:nFWN45N13I:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","BK4007","AKTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670142531","title":"European Equities Traded in the US as American Depositary Receipts Edge Higher in Friday Trading; Down for Week","url":"https://stock-news.laohu8.com/highlight/detail?id=2670142531","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670142531?lang=en_us&edition=fundamental","pubTime":"2026-09-25 23:15","pubTimestamp":1790349322,"startTime":"0","endTime":"0","summary":"European equities traded in the US as American depositary receipts were tracking modestly higher late Friday morning, increasing 0.31% to 1,915.69 on the S&P Europe Select ADR Index, which is down 1.1% for the week.From continental Europe, the gainers were led by semiconductor company Sequans Communications  and medical device maker EDAP TMS , which rose 4% and 2.2% respectively. They were followed by biotech firm Evaxion  and biopharmaceutical company Grifols , which increased 2.3% and 2.2% respectively.The decliners from continental Europe were led by accommodations booking site trivago  and petroleum refiner Equinor , which dropped 1.4% and 1.3% respectively. They were followed by biotech firm BioNTech  and internet browser company Opera , which lost 0.5% and 0.1% respectively.The gainers from the UK were led by software firm Endava  and communications company WPP , which advanced 9.1% and 2.7% respectively. They were followed by lenders Lloyds Banking Group  and Barclays , which in","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["TRVG","BK4134","BK4207","LU0084288595.USD","BCS","LYG","DAVA.AU","BK4007","BK4107","BK4117","BK4521","BK4585","BK4077","BK4548","WPP.AU","BK4139","LFGY","AKTX","AFG","BK4551","BK4009","AMRN","BK4588","BK4082","BK4141","EQNR","BK4201","GRFS","BNTX","OPRA","BK4023","DAVA","FOCL","EPV","IEUR","BCYC","BK4535","EVAX","LU0648005311.SGD","BK4568","NCNA","WPP","SQNS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669616164","title":"European Equities Traded in the US as American depositary Receipts Rise in Monday Trading","url":"https://stock-news.laohu8.com/highlight/detail?id=2669616164","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669616164?lang=en_us&edition=fundamental","pubTime":"2026-09-21 23:29","pubTimestamp":1790004548,"startTime":"0","endTime":"0","summary":"European equities traded in the US as American depositary receipts started the week higher on Monday, rising 0.45% to 1,928.13 on the S&P Europe Select ADR Index.From continental Europe, the gainers from biotech firm BioNTech  and Banco Santander , which advanced 2.1% and 1.7% respectively. They were followed by lenders Banco Bilbao Vizcaya Argentaria  and ING , which increased 1.5% and 1.3% respectively.The decliners from continental Europe were led by pharmaceutical firm Novo Nordisk  and accommodations booking site trivago , which dropped 8% and 3.8% respectively. They were followed by petroleum refiner Equinor  and biopharmaceutical company Cellectis , which lost 2.7% and 1.3% respectively.The gainers from the UK were led by Akari Therapeutics  and software firm Endava , which rose 4% and 3.6%, respectively. They were followed by pharmaceutical companies GSK  and AstraZeneca , which were up 1.5% and 1.2% respectively.The decliners from the UK and Ireland were led by oil and gas com","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4588","LU0006061336.USD","COAL","IE00BKVL7J92.USD","LU0084288595.USD","LU1829250122.USD","IE00B3T34201.USD","LU0072461881.USD","TRVG","SHEH","LU0648005311.SGD","BK4168","BK4585","SHEL","LU1267930573.SGD","BK4521","BK4532","LU0320765992.SGD","LU0098860793.USD","BDRX","GSK","BK4551","LU0310800379.SGD","SLX","LU2237443549.SGD","LU0300736062.USD","BK4139","LU2456880835.USD","BP","LU0708994859.HKD","GSK.UK","BK4134","LU2237443978.SGD","LU1093756325.SGD","LU2089984988.USD","LU2237443895.HKD","BK4207","IE00BZ1G4Q59.USD","LU2237443465.HKD","DAVA","LU1162221912.USD","ING","AKTX","LU0300736492.USD","BK4599","LU0058720904.USD","BK4077","BK4201","LU0128525929.USD","LU0289739699.SGD","LU0109394709.USD","LU2236285917.USD","BK4568","BPH","EQNR","LU2237443382.USD","AZN","AZNH","PPH","GSIB","LU2237443622.USD","BBVA","NVOX","LU0029864427.USD","LU2468319806.SGD","LU1093756168.USD","LU0432979614.USD","BK4535","BK4007","BHP","LU2462157665.USD","BNTX","NVOC","BK4548","THNR","LU0889565916.HKD","LU0320765646.SGD","CLLS","LU0162691827.USD","LU2417539215.USD","OZEM","LU0278409577.USD","LU0154236417.USD","GSKH","SAN","NVO","NVOH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667625364","title":"European Equities Traded in the US as American Depositary Receipts Decline in Tuesday Trading","url":"https://stock-news.laohu8.com/highlight/detail?id=2667625364","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667625364?lang=en_us&edition=fundamental","pubTime":"2026-09-15 23:18","pubTimestamp":1789485515,"startTime":"0","endTime":"0","summary":"European equities traded in the US as American depositary receipts were heading lower late Tuesday morning, declining 0.54% to 1,914.78 on the S&P Europe Select ADR Index.From continental Europe, the gainers were led by telecommunications company Nokia  and petroleum refiner Equinor , which rose 2.5% and 2% respectively. They were followed by medical device maker EDAP  and oil and gas company Eni , which were up 1% and 1.5% respectively.The decliners from continental Europe were led by accommodations booking site trivago  and biopharmaceutical company Cellectis , which fell 2.3% and 11% respectively. They were followed by biopharmaceutical company DBV Technologies  and biotech firm BioNTech , which dropped 3% and 2.6% respectively.The gainers from the UK were led by biopharmaceutical companies Biodexa Pharmaceuticals  and Mereo BioPharma Group , which advanced 15% and 1.8% respectively. They were followed by oil and gas companies Shell  and BP , which increased 1.9% and 2% respectively","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["DRLL","BK4020","DIG","EPV","LU1162221912.USD","FTXN","BK4535","AFG","TRIB","PXE","VDE","BK4568","DBE","AKTX","FOCL","GUSH","BK4201","LNOK","USE","LU0098860793.USD","BCYC","EQNR","DBVT","XES","BNTX","ERX","IEUR","IEO","BK4077","SHEH","CLLS","IXC","LU1829250122.USD","DRIP","BP","DBC","E","LU2236285917.USD","WTIU","BDRX","NOK","PXJ","BK4588","SHEL","TRVG","BPH","SLN","BK4139","MREO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666559281","title":"European Equities Traded in the US as American Depositary Receipts Drop in Thursday Trading","url":"https://stock-news.laohu8.com/highlight/detail?id=2666559281","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666559281?lang=en_us&edition=fundamental","pubTime":"2026-09-10 23:34","pubTimestamp":1789054468,"startTime":"0","endTime":"0","summary":"European equities traded in the US as American depositary receipts were trending lower late Thursday morning, declining 0.41% to 1,938.57 on the S&P Europe Select ADR Index.From continental Europe, the gainers were led by biopharmaceutical company Cellectis  and accommodations booking site trivago , which advanced 1.6% and 1.1% respectively. They were followed by medical device maker EDAP TMS  and 3D printer company Materialise , which increased 1.2% and 0.8% respectively.The decliners from continental Europe were led by biotech firm Evaxion  and biopharmaceutical company DBV Technologies , which lost 5% and 2.7% respectively. They were followed by biotech firm BioNTech  and biopharmaceutical company Grifols , which were down 1.8% and 1.7% respectively.The gainers from the UK were led by software firm Endava  and biopharmaceutical company Akari Therapeutics , which were up 2% and 1.6% respectively. They were followed by telecommunications operator Vodafone Group  and pharmaceutical com","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4082","EPV","LU2456880835.USD","BK4139","SLX","AFG","FOCL","LU0648005311.SGD","IEUR","BK4077","BK4535","BK4532","LU0310800379.SGD","AKTX","LU0029864427.USD","AZN","BDRX","AMRN","BK4134","AZNH","BK4551","GRFS","LU2237443622.USD","LU0708994859.HKD","DBVT","LU2237443465.HKD","LU2468319806.SGD","EVAX","BK4107","BHP.AU","MTLS","LU1829250122.USD","BK4548","COAL","LU0128525929.USD","DAVA","LU0300736062.USD","LU0058720904.USD","BHP","BNTX","DAVA.AU","PRNT","BK4568","CLLS","LU0320765992.SGD","LU2462157665.USD","VOD","BK4546","TRVG","TRIB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666531522","title":"European Equities Traded in the US as American Depositary Receipts Decline in Wednesday Trading","url":"https://stock-news.laohu8.com/highlight/detail?id=2666531522","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666531522?lang=en_us&edition=fundamental","pubTime":"2026-09-09 23:30","pubTimestamp":1788967837,"startTime":"0","endTime":"0","summary":"European equities traded in the US as American depositary receipts were trending lower late Wednesday morning, declining 0.46% to 1,952.20 on the S&P Europe Select ADR Index.From continental Europe, the gainers were led by petroleum refiner Equinor  and biotech firm Evaxion , which advanced 4% and 3.5% respectively. They were followed by telecommunications company Nokia  and oil and gas company Eni , which increased 2.1% and 1.4% respectively.The decliners from continental Europe were led by brewing company Anheuser-Busch InBev  and biopharmaceutical company Cellectis , which dropped 2.1% and 1.9% respectively. They were followed by lender Banco Santander  and internet browser company Opera , which lost 1.7% and 1.6% respectively.The gainers from the UK were led by biopharmaceutical company Akari Therapeutics  and biotech firm Trinity Biotech , which rose 3.7% and 3.6% respectively. They were followed by pharmaceutical company Silence Therapeutics  and oil and gas company BP , which we","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["DIG","DRIP","BPH","BUD","ERX","EQNR","BK4023","IEUR","BK7142","MREO","DRLL","BK4107","OPRA","VDE","LFGY","DBC","AUTL","BP","SLN","XES","IXC","WTIU","IEO","DBE","USE","NOK","BUD.AU","CLLS","PXJ","SAN.AU","BCYC","EPV","GUSH","PXE","BK4158","BK4547","BK7119","EVAX","FTXN","GSIB","TRIB","E","BK4082","BK4020","BK4201","AKTX","SAN","AFG","BCS","LNOK"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665537914","title":"European Equities Traded in the US as American Depositary Receipts Fall in Tuesday Trading","url":"https://stock-news.laohu8.com/highlight/detail?id=2665537914","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665537914?lang=en_us&edition=fundamental","pubTime":"2026-09-08 23:28","pubTimestamp":1788881328,"startTime":"0","endTime":"0","summary":"European equities traded in the US as American depositary receipts were tracking lower late Tuesday morning, declining 0.46% to 1,968.02 on the S&P Europe Select ADR Index.From continental Europe, the gainers were led by biotech firm Evaxion  and telecommunications company Nokia , which rose 2.6% and 6.5% respectively. They were followed by petroleum refiner Equinor  and oil and gas company Eni , which were up 2.3% and 2.2% respectively.The decliners from continental Europe were led by biotech firm BioNTech  and internet browser company Opera , which fell 4.9% and 2% respectively. They were followed by biopharmaceutical companies argenx  and Cellectis , which were down 2.2% and 0.3%, respectively.The gainers from the UK were led by biopharmaceutical company Akari Therapeutics  and oil and gas company BP , which increased 2% and 2.5% respectively. They were followed by mining company BHP Group  and oil and gas company Shell , which advanced 3.4% and 2.5% respectively.The decliners from ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BHP","BK4020","GUSH","DAVA.AU","IE00BFTCPJ56.SGD","OPRA","SLX","NOK","VDE","IE00BJT1NW94.SGD","LNOK","DBC","ERX","IEUR","DIG","SHEH","EPV","EQNR","FTXN","IEO","TBXU","AFG","BP","PXJ","WTIU","BPH","BHP.AU","USE","XES","EVAX","FMED","DRIP","IXC","AUTL","DBE","E","LU0648005311.SGD","AKTX","DAVA","LFGY","PXE","ARGX","BNTX","IBB","SHEL","DRLL","COAL","CLLS","SLN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665737563","title":"Akari Therapeutics to Present PH1 ADC Payload Platform at Oncology and Investor Conferences","url":"https://stock-news.laohu8.com/highlight/detail?id=2665737563","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665737563?lang=en_us&edition=fundamental","pubTime":"2026-09-08 21:15","pubTimestamp":1788873351,"startTime":"0","endTime":"0","summary":"Akari Therapeutics to present PH1 ADC payload platform at oncology and investor conferencesAkari will present its PH1 ADC payload platform at conferences in September 2026 across the U.S. and China.CE","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260908:nNDL15XWpL:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0314104364.USD","LU2210150020.SGD","AKTX","BK0167","SG9999014013.SGD","NDAQ","300615","BK4112","LU2095319765.USD","IE00B3QW5Z07.USD","IE00BQXX3C00.GBP","IE00BKPKM429.USD","IE00BN0W2W23.USD","SG9999014005.SGD","BK4007","BK0214","BK4588","SG9999014039.USD","IE00B64PRP62.GBP","IE00BN0W2T93.GBP","IE00BQXX3D17.EUR","SG9999014021.USD","IE00BGHQF748.EUR","BCDF","IE00BN0W2V16.EUR","LU2210149790.SGD","BK4139","IE00BQXX3F31.USD","BK4585"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.akaritx.com","stockEarnings":[{"period":"1week","weight":0.1759},{"period":"1month","weight":0.0142},{"period":"3month","weight":-0.053},{"period":"6month","weight":0.5483},{"period":"1year","weight":-0.6984},{"period":"ytd","weight":-0.1964}],"compareEarnings":[{"period":"1week","weight":-0.0115},{"period":"1month","weight":0.0097},{"period":"3month","weight":0.029},{"period":"6month","weight":0.0855},{"period":"1year","weight":0.1456},{"period":"ytd","weight":0.1278}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"Akari Therapeutics, Plc, a clinical-stage biopharmaceutical company, focuses on developing advanced therapies for autoimmune and inflammatory diseases. Its lead product candidate is nomacopan, a second-generation complement inhibitor that prevents inflammatory and prothrombotic activities. The company also develops PASylated-nomacopan, which is in preclinical development for the treatment of geographic atrophy secondary to dry age-related macular degeneration; and hematopoietic stem cell transplant-related thrombotic microangiopathy (HSCT-TMA) combined with nomacopan, which is in phase 3 clinical development for the treatment of pediatric HSCT-TMA. The company is headquartered in Boston, Massachusetts.","yearOnYearQuotes":[{"month":1,"riseRate":0.416667,"avgChangeRate":0.007289},{"month":2,"riseRate":0.25,"avgChangeRate":-0.164819},{"month":3,"riseRate":0.384615,"avgChangeRate":0.051328},{"month":4,"riseRate":0.461538,"avgChangeRate":0.052868},{"month":5,"riseRate":0.230769,"avgChangeRate":0.014482},{"month":6,"riseRate":0.461538,"avgChangeRate":0.016983},{"month":7,"riseRate":0.307692,"avgChangeRate":0.004368},{"month":8,"riseRate":0.538462,"avgChangeRate":0.238706},{"month":9,"riseRate":0.461538,"avgChangeRate":0.035351},{"month":10,"riseRate":0.230769,"avgChangeRate":-0.120916},{"month":11,"riseRate":0.416667,"avgChangeRate":-0.07207},{"month":12,"riseRate":0.25,"avgChangeRate":-0.096768}],"exchange":"NASDAQ","name":"Akari Therapeutics PLC","nameEN":"Akari Therapeutics PLC","securityTypeName":"DR","adrRate":"1:80000"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.52.0","shortVersion":"4.52.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Akari Therapeutics PLC(AKTX),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Akari Therapeutics PLC(AKTX) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Akari Therapeutics PLC,AKTX,Akari Therapeutics PLC股票,Akari Therapeutics PLC股票老虎,Akari Therapeutics PLC股票老虎国际,Akari Therapeutics PLC行情,Akari Therapeutics PLC股票行情,Akari Therapeutics PLC股价,Akari Therapeutics PLC股市,Akari Therapeutics PLC股票价格,Akari Therapeutics PLC股票交易,Akari Therapeutics PLC股票购买,Akari Therapeutics PLC股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Akari Therapeutics PLC(AKTX),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Akari Therapeutics PLC(AKTX) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}

Introduction